Literature DB >> 16784027

MicroRNAs: small but potent oncogenes or tumor suppressors.

Yong Sun Lee1, Anindya Dutta.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that modulate the expression of target mRNA. Many miRNAs are known to be up- or downregulated in a variety of cancers, suggesting a role for miRNAs in tumorigenesis. The correlation between the expression of miRNAs and their effects on target oncogenes, on tumorigenesis and on the proliferation of cancer cells is beginning to gain experimental evidence. For example, the miRNA (miR)-17-92 cluster has been characterized as an oncogene, while let-7 represses Ras and miR-15a/-16-1 represses Bcl-2, thereby acting as tumor suppressors. Thus, an oncogenic or tumor suppressive miRNA may have potential as a therapeutic target to control cancers. This review will discuss the relationship between miRNAs and tumorigenesis, and the potential for modulating miRNAs for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784027

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  45 in total

Review 1.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

2.  MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits.

Authors:  J-E Lee; E-J Hong; H-Y Nam; J-W Kim; B-G Han; J-P Jeon
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

Review 3.  MicroRNAs in opioid pharmacology.

Authors:  Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-09       Impact factor: 4.147

4.  MicroRNA expression profiles predictive of human renal allograft status.

Authors:  Dany Anglicheau; Vijay K Sharma; Ruchuang Ding; Aurélie Hummel; Catherine Snopkowski; Darshana Dadhania; Surya V Seshan; Manikkam Suthanthiran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

5.  Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p.

Authors:  Yingying Su; Zhaohui Ni; Guoqing Wang; Juan Cui; Chengguo Wei; Jihan Wang; Qing Yang; Ying Xu; Fan Li
Journal:  Int Immunopharmacol       Date:  2012-06-07       Impact factor: 4.932

6.  Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.

Authors:  Yong Yang; Peng Zhang; Yanfeng Zhao; Jie Yang; Gening Jiang; Jie Fan
Journal:  Cancer Biol Ther       Date:  2015-10-22       Impact factor: 4.742

7.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

8.  MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

Authors:  Qingchuan Dong; Ping Meng; Tao Wang; Weiwei Qin; Weijun Qin; Fuli Wang; Jianlin Yuan; Zhinan Chen; Angang Yang; He Wang
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

9.  Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.

Authors:  Kwang-Hyuck Lee; Craig Lotterman; Collins Karikari; Noriyuki Omura; Georg Feldmann; Nils Habbe; Michael G Goggins; Joshua T Mendell; Anirban Maitra
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996

10.  Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells.

Authors:  Bing Zhao; Xiabao Hou; Hui Zhan
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.